Tijl Vermassen

Exploring the landscape of academic research

Charlotte Bertrand, France Vrijens, Marielle Sautois, Sofie De Vos, Levi Hoste (UGent) and Tijl Vermassen (UGent)

(2025) Healixia Clinical Conference 2025, Abstracts.

Add to list

Conference Paper
C3
open access

Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Gabriële Holtappels (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Amber Meskens (UGent) , Sara Neyt (UGent) , et al.

(2025) 38th Annual Congress of the European Association of Nuclear Medicine - Abstracts. In EANM Innovation 1. p.s238-s239

Add to list

Conference Paper
C3
open access

Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Sylvie Rottey (UGent) , Michael Saerens (UGent) , et al.

(2025) 11th European Congress on Head & Neck Oncology, Abstracts.

Add to list

A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer

Lissa Eggermont (UGent) , Nicolaas Lumen (UGent) , Charles Van Praet (UGent) , Joris Delanghe (UGent) , Sylvie Rottey (UGent) and Tijl Vermassen (UGent)

(2025) BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 1880(1).

Add to list

Journal Article
A1
open access

Prognostication of brain-metastasized patients receiving subsequent systemic therapy : a single-center long-term follow-up

Tijl Vermassen (UGent) , Charlotte Van Parijs, Stijn De Keukeleire (UGent) , Katrien Vandecasteele (UGent) and Sylvie Rottey (UGent)

(2025) CURRENT ONCOLOGY. 32(2).

Add to list

Journal Article
A1
open access

Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients

Tijl Vermassen (UGent) , Karen Geboes (UGent) , Nicolaas Lumen (UGent) , Charles Van Praet (UGent) , Sylvie Rottey (UGent) and Joris Delanghe (UGent)

(2024) CLINICAL KIDNEY JOURNAL. 17(1).

Add to list

Conference Paper
C3
open access

Weekly vs 3-weekly cisplatin : a retrospective cohort study

Michael Saerens (UGent) , Alexander Van den Broeck (UGent) , Geertrui Van de Weghe, Wouter Huvenne (UGent) , Peter Tomassen (UGent) , Wouter Bauters (UGent) , Tijl Vermassen (UGent) , Sarah Deschuymer (UGent) , Sylvie Rottey (UGent) and Fréderic Duprez (UGent)

(2024) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 192(Supplement 1). p.S280-S283

Add to list

Divergent fates : the ambiguous role of M2-like TAMs in oropharyngeal cancer

Michael Saerens (UGent) , Michel Struys (UGent) , Wouter Huvenne (UGent) , Sylvie Rottey (UGent) , Fleur Cordier (UGent) , S Fadei, David Creytens (UGent) , W Waelput, Tijl Vermassen (UGent) and Jens Debacker (UGent)

(2024) ANNALS OF ONCOLOGY. In Annals of Oncology 35(Supplement 2). p.S645-S645

Add to list

Journal Article
A1
open access

The association between urine N-glycome and prognosis after initial therapy for primary prostate cancer

Tijl Vermassen (UGent) , Nicolaas Lumen (UGent) , Charles Van Praet (UGent) , Nico Callewaert (UGent) , Joris Delanghe (UGent) and Sylvie Rottey (UGent)

(2024) BIOMEDICINES. 12(5).

Add to list

Journal Article
A1
open access

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract : a long-term comparative study

Tijl Vermassen (UGent) , Stijn De Keukeleire (UGent) , Michael Saerens (UGent) , Sylvester Heerwegh, Jens Debacker (UGent) , Wouter Huvenne (UGent) , Philippe Deron (UGent) , David Creytens (UGent) , Liesbeth Ferdinande (UGent) , Sylvie Rottey (UGent) , et al.

(2024) EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 281(6). p.2993-3004

Academic Bibliography

Tijl Vermassen

Exploring the landscape of academic research

Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer

Prognostication of brain-metastasized patients receiving subsequent systemic therapy : a single-center long-term follow-up

Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients

Weekly vs 3-weekly cisplatin : a retrospective cohort study

Divergent fates : the ambiguous role of M2-like TAMs in oropharyngeal cancer

The association between urine N-glycome and prognosis after initial therapy for primary prostate cancer

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract : a long-term comparative study

Contents

Support

Contact